Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by LIFECORE BIOMEDICAL, INC. on October 29, 2025. The record date for the meeting was September 2, 2025. The filing details the voting outcomes for three proposals: the election of directors, the ratification of the independent auditor, and an advisory vote on executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The following material events occurred during the Annual Meeting:
- Director Elections: Nine directors were elected to serve until the 2026 Annual Meeting.
- Class I Directors (Elected by Common and Series A Preferred Stockholders): Katrina L. Houde, Humberto C. Antunes, Paul H. Johnson, Paul Josephs, Matthew E. Korenberg, Nelson Obus, and Joshua E. Schechter were elected. Voting support ranged from approximately 89% to 98% of votes cast.
- Series A Preferred Directors: Jason Aryeh and Christopher S. Kiper were elected solely by Series A Preferred Stockholders with unanimous support (38,776 votes for each).
- Auditor Ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal received 35,663,643 votes for, 15,326 against, and 68,718 abstentions.
- Executive Compensation: Stockholders approved the non-binding advisory proposal regarding the compensation of named executive officers. The proposal received 24,642,130 votes for, 238,354 against, and 80,394 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Investor Verification Checklist
- Verify the composition of the new Board of Directors, specifically the seven directors elected by the combined class and the two Series A Preferred Directors.
- Confirm the appointment of KPMG LLP as the independent auditor for the fiscal year ending December 31, 2025.
- Review the proxy statement for details on the specific compensation packages approved in the advisory vote.
- Note the significant number of broker non-votes (10,786,809) recorded for the director elections and executive compensation vote.